ketamine has been researched along with Cholangiitis, Sclerosing in 2 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knooihuizen, SAI | 1 |
| Aday, A | 1 |
| Lee, WM | 1 |
| Turkish, A | 1 |
| Luo, JJ | 1 |
| Lefkowitch, JH | 1 |
2 other studies available for ketamine and Cholangiitis, Sclerosing
| Article | Year |
|---|---|
Ketamine-Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient With COVID-19.
Topics: Anesthetics, Dissociative; Biliary Tract; Cholangitis, Sclerosing; Conscious Sedation; COVID-19; Fem | 2021 |
Ketamine abuse, biliary tract disease, and secondary sclerosing cholangitis.
Topics: Administration, Inhalation; Anesthetics, Dissociative; Biliary Tract Diseases; Biopsy; Cholangitis, | 2013 |